NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/31/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization73.58 mln
Float4.37 mln
Earnings Date11/05/2026
Piotroski F-Score
3
/ 9
Below average
1-Year Forecast
17.33
Transformational upside
Relative Strength
81
/ 100
Strongly outperforming
Debt / Equity
0.01
Debt-free
ROE
-374
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
LeonaBio Inc., formerly Athira Pharma, is a clinical-stage company based in Bothell, Washington, working to develop treatments that protect and restore brain cell health. Its two lead drug candidates, ATH-1105 and ATH-1020, are both in early-stage human trials targeting conditions such as ALS and other diseases that cause the brain and nervous system to deteriorate over time. The company also has additional treatments in earlier stages of research and development.
